Drug Risks

The Ninth Circuit ruled that a putative class of patients and third-party payers of health and welfare benefits have satisfied RICO’s proximate cause requirement in their suit claiming pharmaceutical companies refused to inform the public that the drug Actos increased a patient’s risk of bladder cancer.

SEATTLE – The Ninth Circuit ruled that a putative class of patients and third-party payers of health and welfare benefits have satisfied RICO’s proximate cause requirement in their suit claiming pharmaceutical companies refused to inform the public that the drug Actos increased a patient’s risk of bladder cancer.

Categories / Appeals, Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Drug Risks

Subscribe to Closing Arguments

Additional Reads